These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Secretion of RANTES (CCL5) and interleukin-10 from mesenteric adipose tissue and from creeping fat in Crohn's disease: regulation by steroid treatment. Schäffler A; Fürst A; Büchler C; Paul G; Rogler G; Schölmerich J; Herfarth H J Gastroenterol Hepatol; 2006 Sep; 21(9):1412-8. PubMed ID: 16911685 [TBL] [Abstract][Full Text] [Related]
5. Mesenteric Adipocyte Dysfunction in Crohn's Disease is Associated with Hypoxia. Zuo L; Li Y; Zhu W; Shen B; Gong J; Guo Z; Zhang W; Wu R; Gu L; Li N; Li J Inflamm Bowel Dis; 2016 Jan; 22(1):114-26. PubMed ID: 26332309 [TBL] [Abstract][Full Text] [Related]
6. Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis. Clemente TR; Dos Santos AN; Sturaro JN; Gotardo EM; de Oliveira CC; Acedo SC; Caria CR; Pedrazzoli J; Ribeiro ML; Gambero A Scand J Gastroenterol; 2012 Sep; 47(8-9):943-50. PubMed ID: 22630819 [TBL] [Abstract][Full Text] [Related]
7. Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease. Rodrigues VS; Milanski M; Fagundes JJ; Torsoni AS; Ayrizono ML; Nunez CE; Dias CB; Meirelles LR; Dalal S; Coy CS; Velloso LA; Leal RF Clin Exp Immunol; 2012 Dec; 170(3):358-64. PubMed ID: 23121676 [TBL] [Abstract][Full Text] [Related]
8. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients. Jan V; Cervera P; Maachi M; Baudrimont M; Kim M; Vidal H; Girard PM; Levan P; Rozenbaum W; Lombès A; Capeau J; Bastard JP Antivir Ther; 2004 Aug; 9(4):555-64. PubMed ID: 15456087 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor secretion from mesenteric adipose tissue and from creeping fat in Crohn's disease. Schäffler A; Fürst A; Büchler C; Paul G; Rogler G; Schölmerich J; Herfarth H J Gastroenterol Hepatol; 2006 Sep; 21(9):1419-23. PubMed ID: 16911686 [TBL] [Abstract][Full Text] [Related]
10. Exclusive enteral nutrition ameliorates mesenteric adipose tissue alterations in patients with active Crohn's disease. Feng Y; Li Y; Mei S; Zhang L; Gong J; Gu L; Zhang W; Zhu W; Li N; Li J Clin Nutr; 2014 Oct; 33(5):850-8. PubMed ID: 24200200 [TBL] [Abstract][Full Text] [Related]
11. Mesenteric Adipose Tissue Alterations in Crohn's Disease Are Associated With the Lymphatic System. Shen W; Li Y; Zou Y; Cao L; Cai X; Gong J; Xu Y; Zhu W Inflamm Bowel Dis; 2019 Jan; 25(2):283-293. PubMed ID: 30295909 [TBL] [Abstract][Full Text] [Related]
12. Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease. Kredel LI; Batra A; Stroh T; Kühl AA; Zeitz M; Erben U; Siegmund B Gut; 2013 Jun; 62(6):852-62. PubMed ID: 22543156 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Desreumaux P; Ernst O; Geboes K; Gambiez L; Berrebi D; Müller-Alouf H; Hafraoui S; Emilie D; Ectors N; Peuchmaur M; Cortot A; Capron M; Auwerx J; Colombel JF Gastroenterology; 1999 Jul; 117(1):73-81. PubMed ID: 10381912 [TBL] [Abstract][Full Text] [Related]
14. Autophagy is decreased in mesenteric fat tissue but not in intestinal mucosae of patients with Crohn's disease. Leal RF; Coy CS; Velloso LA; Dalal S; Portovedo M; Rodrigues VS; Coope A; Ayrizono ML; Fagundes JJ; Milanski M Cell Tissue Res; 2012 Dec; 350(3):549-52. PubMed ID: 22948252 [TBL] [Abstract][Full Text] [Related]
15. Disturbance of Fatty Acid Desaturation Mediated by FADS2 in Mesenteric Adipocytes Contributes to Chronic Inflammation of Crohn's Disease. Liu R; Qiao S; Shen W; Liu Y; Lu Y; Liangyu H; Guo Z; Gong J; Shui G; Li Y; Zhu W J Crohns Colitis; 2020 Nov; 14(11):1581-1599. PubMed ID: 32365195 [TBL] [Abstract][Full Text] [Related]
16. Cadmium reduces adipocyte size and expression levels of adiponectin and Peg1/Mest in adipose tissue. Kawakami T; Sugimoto H; Furuichi R; Kadota Y; Inoue M; Setsu K; Suzuki S; Sato M Toxicology; 2010 Jan; 267(1-3):20-6. PubMed ID: 19666079 [TBL] [Abstract][Full Text] [Related]
17. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Paul G; Schäffler A; Neumeier M; Fürst A; Bataillle F; Buechler C; Müller-Ladner U; Schölmerich J; Rogler G; Herfarth H Inflamm Bowel Dis; 2006 Jun; 12(6):471-7. PubMed ID: 16775490 [TBL] [Abstract][Full Text] [Related]
18. Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease. Michalski CW; Autschbach F; Selvaggi F; Shi X; Di Mola FF; Roggo A; Müller MW; Di Sebastiano P; Büchler MW; Giese T; Friess H Am J Surg; 2007 Apr; 193(4):476-81. PubMed ID: 17368292 [TBL] [Abstract][Full Text] [Related]
19. Perinodal adipose tissue and fatty acid composition of lymphoid tissues in patients with and without Crohn's disease and their implications for the etiology and treatment of CD. Westcott ED; Mattacks CA; Windsor AC; Knight SC; Pond CM Ann N Y Acad Sci; 2006 Aug; 1072():395-400. PubMed ID: 17057221 [TBL] [Abstract][Full Text] [Related]
20. Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. Mencarelli A; Distrutti E; Renga B; D'Amore C; Cipriani S; Palladino G; Donini A; Ricci P; Fiorucci S PLoS One; 2011; 6(7):e22978. PubMed ID: 21829567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]